DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Noto RB, Pryma DA, Jensen J. et al.
Phase 1 study of high-specific-activity I-131 MIBG for metastatic and/or recurrent pheochromocytoma or paraganglioma.
J Clin Endocrinol Metab 2018;
103: 213-220
DOI: 10.1210/jc.2017-02030. (PMID: 29099942)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.